Facebook

PHFI

Working towards a healthier India
PHFI is helping to build institutional and systems capacity in India for strengthening education, training, research and policy development in the area of Public Health.

Our Diabetes Projects PDF Print

Diabetes

Diabetes and hypertension are increasing rapidly in India. Despite availability of proven and effective prevention strategies and treatments, the detection and control rates of diabetes and hypertension are abysmally low and the numbers worrisome:

  • India has the highest number of diabetics in the world and annual coronary deaths are expected to reach 2 million by 2010.
  • In India, 69 million people currently have diabetes; 124 million will have by 2030.
  • Cardiovascular disease (CVD) is the major cause of death and disability in people with diabetes.
  • Up to 75% of CVD in people with diabetes is attributable to co-existent hypertension.
  • Hypertension is a contributing factor to diabetic complications: retinopathy, nephropathy and amputation.

Thus, great potential and opportunity exists to reduce this rising burden through concomitantly improving their prevention, detection and control. At CCCI, we undertake various research programmes that comprehensively address the whole continuum of care from prevention, to detection and management.

UDAY - A comprehensive diabetes and hypertension prevention and management program in India

Name Funding Body Duration Status Team
UDAY - A comprehensive diabetes and hypertension prevention and management program in India. Eli Lilly and Company under the Lilly NCD partnership 2013-2018 Ongoing Investigators: Sailesh Mohan, K. Srinath Reddy, D. Prabhakaran, Nikhil Tandon, Bhaskara Rao, Sanjay Kalra Research Staff: Prashant Jarhyan, Nikhil SV, Shreeparna Ghosh, Balaji Gummidi, Yogesh Kumar, Admin and Finance staff: Sanjeev Aggarwal

 

About

UDAY aims to improve the prevention, detection and management of diabetes and hypertension in the selected study sites through a multi-component, multi-level, comprehensive intervention program. It is being implemented in two geographically and culturally distinct sites, Sonipat district (Haryana) and Visakhapatnam district (Andhra Pradesh), and cover a total population of about 400000. UDAY has a pre-post evaluation study design. The baseline health assessments (among the general population, patients, facilities, providers, GIS mapping) have been completed. The following interventions are currently being implemented: screening of individuals (≥30 years) for diabetes, hypertension and referring those at high risk to the health system, culturally tailored health promotion campaign to increase the public’s awareness regarding diabetes, hypertension and chronic disease risk factors, capacity building of healthcare providers (physicians, nurses, pharmacists and community health workers) for advancing guideline based management of diabetes and hypertension, patient education to promote medication adherence and self-management, diabetes and hypertension registries to improve the quality of care. Midline and end line assessments will be used to assess likely impact.

Participants

PHFI is the lead partner; Project Hope and PSI India are the other partners

Media Coverage: http://www.udaydiabetes.org/PressCoverage.aspx

Website: http://www.udaydiabetes.org/

Prevention of type 2 diabetes in women with gestational diabetes in urban India – a feasibility study

Name Funding Body Duration Status Team
Prevention of type 2 diabetes in women with gestational diabetes in urban India – a feasibility study BRIDGES, International Diabetes Federation 2010-2014 Completed PI- Prof. Nikhil Tandon Co-I’s: Prof. D. Prabhakaran, Prof. Anushka Patel, Dr. Rohina Joshi, Dr. Ankush Desai

 

About

This study is a phase 2 trial of lifestyle behavioral changes to prevent gestational diabetes. Gestational diabetes (GDM) is a strong risk factor for developing type 2 diabetes mellitus. GDM and type 2 diabetes are both common among Indian women. Limited information about lifestyle programs to prevent or delay diabetes in women with GDM is available from other countries, but their applicability in India is unknown. We are evaluating the feasibility of adapting such programs by making them culturally appropriate to the Indian context and testing them in a small group of patients. The study is being carried out at All India Institute of Medical Sciences and the Centre for Fertility Management, Hyderabad with the aim of recruiting a total of 250 pregnant women with gestational diabetes. The results from this study will allow us to refine the program and perform a larger study to conclusively determine its generalizability and sustainability in urban India.

Publications

  • 8th annual conference of RSSDI Chapter Meeting, Delhi (India), September 2012
  • World Diabetes Congress, Melbourne (Australia), December 2013
  • Steering committee meeting organized by National Heart, Lung and Blood Institute, Bethesda (USA), April 2014
  • Gupta Y, Bhatla N, Patel A, Prabhakaran D, Joshi R, Desai A ,Kapoor D, Rozati R, Dodameni S, Gupta N, D Praveen, Reddy P, Tandon N. The Conversion of Gestational Diabetes Mellitus to Future Type 2 Diabetes Mellitus and The Predictive Value Of Hba1c In An Indian Cohort. Submitted at Diabetic Medicine on 31st August (DME-2015-00701)
 
Last Modified : April 16, 2016, 4:29 pm